Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × Sodium Chloride × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Leukemia, Myeloid, Acute 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Skin Neoplasms 1 Recurrence 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Platinum Resistant Ovarian Cancer 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphopenia 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hot Flashes 1 Hodgkin Disease 1 Gangliosidosis, GM1 1 Gangliosidoses 1 Fatigue 1 Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 21 Dexamethasone 19 Rituximab 16 Cytarabine 16 fludarabine 10 Methotrexate 10 Gemcitabine 10 Bortezomib 10 Lenalidomide 9 Filgrastim 9 Etoposide 8 pembrolizumab 7 Vincristine 7 Paclitaxel 7 Cyclosporine 7 carfilzomib 6 Topotecan 6 Temozolomide 6 Docetaxel 6 Calcium Dobesilate 6 Antilymphocyte Serum 6 pomalidomide 5 fludarabine phosphate 5 Radiotherapy 5 Peripheral Blood Stem Cell Transplantation 5 Pemetrexed 5 Mitoxantrone 5 Granulocyte Colony-Stimulating Factor 5 Doxorubicin 5 Azacitidine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00925548 2014-07-24

STRIDE

EMD Serono

Phase 3 Terminated

16 enrolled 6 charts

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡